“Plans for the future are ambitious as regards exports. Romania is the biggest market for us at present, but for us to double turnover in 5-7 years, we must focus a lot on exports, which we’ve started doing,” stated Catalin Vicol, Biofarm general manager.
As future export targets, the company looks at several major regions, such as southeastern Asia, Africa, the Middle East and central Asia, but does not overlook CEE.
Last year, the company delivered 25 million drug units.
(English version by Catalina Apostoiu)